The University of Chicago Header Logo

Connection

Hedy Kindler to Proteasome Inhibitors

Back to Details
This is a "connection" page, showing publications Hedy Kindler has written about Proteasome Inhibitors.
Hedy Kindler
Connection Strength
0.087
Proteasome Inhibitors
  1. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):549-58.
    View in: PubMed
    Score: 0.072
  2. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):6111-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.